Wim Robberecht

28.9k total citations · 5 hit papers
133 papers, 11.4k citations indexed

About

Wim Robberecht is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Wim Robberecht has authored 133 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Neurology, 76 papers in Genetics and 26 papers in Molecular Biology. Recurrent topics in Wim Robberecht's work include Amyotrophic Lateral Sclerosis Research (122 papers), Neurogenetic and Muscular Disorders Research (76 papers) and Parkinson's Disease Mechanisms and Treatments (37 papers). Wim Robberecht is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (122 papers), Neurogenetic and Muscular Disorders Research (76 papers) and Parkinson's Disease Mechanisms and Treatments (37 papers). Wim Robberecht collaborates with scholars based in Belgium, United States and United Kingdom. Wim Robberecht's co-authors include Ludo Van Den Bosch, Thomas Philips, Philip Van Damme, Bart Swinnen, Elke Bogaert, Pamela J. Shaw, Leonard H. van den Berg, Adriano Chiò, Ammar Al‐Chalabi and Orla Hardiman and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and The Journal of Cell Biology.

In The Last Decade

Wim Robberecht

133 papers receiving 11.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyotrophic lateral sclerosis

2017 944 citations Ammar Al‐Chalabi, Wim Robberecht et al. profile →
The changing scene of amyotrophic lateral sclerosis

2013 756 citations Wim Robberecht, Thomas Philips Nature reviews. Neuroscience profile →
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

2011 497 citations Thomas Philips, Wim Robberecht profile →
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS

2015 446 citations Steven Boeynaems, Elke Bogaert et al. profile →
The phenotypic variability of amyotrophic lateral sclerosis

2014 428 citations Bart Swinnen, Wim Robberecht profile →

Peers

Countries citing papers authored by Wim Robberecht

Since Specialization

Citations

This map shows the geographic impact of Wim Robberecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Robberecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Robberecht more than expected).

Fields of papers citing papers by Wim Robberecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Robberecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Robberecht. The network helps show where Wim Robberecht may publish in the future.

Co-authorship network of co-authors of Wim Robberecht

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Robberecht. A scholar is included among the top collaborators of Wim Robberecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Robberecht. Wim Robberecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Elisabeth Rossaert, Sandra Duqué, Laura Rué, André Bento‐Abreu, Nicole Hersmus, (unknown), Axelle Kerstens, Nikky Corthout, Sebastian Munck, Philip Van Damme, Matthew G. Holt, Georg von Jonquières, Matthias Klugmann, Ludo Van Den Bosch, Wim Robberecht	16
2	RNA toxicity in non‐coding repeat expansion disorders 2019 ·The EMBO Journal ·Bart Swinnen, Wim Robberecht, Ludo Van Den Bosch	117
3	FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins 2018 ·Human Molecular Genetics ·(unknown), Wendy Scheveneels, (unknown), Philip Van Damme, Wim Robberecht, Patrick Callaerts, Elke Bogaert, Ludo Van Den Bosch	36
4	A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism 2018 ·Acta Neuropathologica ·Bart Swinnen, André Bento‐Abreu, Tania F. Gendron, Steven Boeynaems, Elke Bogaert, (unknown), Mieke Timmers, Wendy Scheveneels, Nicole Hersmus, Jiou Wang, Sarah Mizielinska, Adrian M. Isaacs, Leonard Petrucelli, Robin Lemmens, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht	88
5	Conditional deletion of Id2 or Notch1 in oligodendrocyte progenitor cells does not ameliorate disease outcome in SOD1G93A mice 2018 ·Neurobiology of Aging ·(unknown), Annelies Nonneman, Cathy Jensen, Antonio Iavarone, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht	7
6	Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice 2014 ·Molecular Neurodegeneration ·(unknown), Carla Cirillo, Ludo Van Den Bosch, Wim Robberecht, Pieter Vanden Berghe, Philip Van Damme	58
7	Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke 2013 ·Human Molecular Genetics ·Robin Lemmens, Tom Jaspers, Wim Robberecht, Vincent Thijs	46
8	Non-invasive ventilation in amyotrophic lateral sclerosis 2013 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Bart Vrijsen, Dries Testelmans, Catharina Belge, Wim Robberecht, Philip Van Damme, Bertien Buyse	21
9	The changing scene of amyotrophic lateral sclerosis breakdown → 2013 ·Nature reviews. Neuroscience ·Wim Robberecht, Thomas Philips	756
10	Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice 2013 ·Neurobiology of Disease ·Kim A. Staats, Lawrence Van Helleputte, Ashley Jones, André Bento‐Abreu, Annelies Van Hoecke, Aleksey Shatunov, Claire L. Simpson, Robin Lemmens, Tom Jaspers, Kiyoko Fukami, Yoshikazu Nakamura, Robert H. Brown, Philip Van Damme, Adrian Liston, Wim Robberecht, Ammar Al‐Chalabi, Ludo Van Den Bosch	14
11	Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study 2013 ·Neurobiology of Aging ·Sarah Debray, Valérie Race, (unknown), (unknown), Gert Matthijs, An Goris, Bénédicte Dubois, Vincent Thijs, Wim Robberecht, Philip Van Damme	30
12	Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats 2013 ·Neurobiology of Aging ·(unknown), Louis De Muynck, Ludo Van Den Bosch, Wim Robberecht, Philip Van Damme	10
13	The neurobiology of amyotrophic lateral sclerosis 2010 ·European Journal of Neuroscience ·André Bento‐Abreu, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht	65
14	Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 2008 ·Journal of Neuroscience ·Genevíève Gowing, Thomas Philips, Bart Van Wijmeersch, Jean‐Nicolas Audet, Maarten Dewil, Ludo Van Den Bosch, An Billiau, Wim Robberecht, Jean-Pierre Julien	114
15	Over‐expression of Hsp27 does not influence disease in the mutant SOD1^G93A mouse model of amyotrophic lateral sclerosis 2008 ·Journal of Neurochemistry ·Jyothsna Krishnan, (unknown), Maria Andries, Etienne Waelkens, Wim Robberecht, Ludo Van Den Bosch	38
16	Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS 2007 ·Ghent University Academic Bibliography (Ghent University) ·Ilse Gijselinck, Kristel Sleegers, Sebastiaan Engelborghs, Wim Robberecht, Jean‐Jacques Martin, Rik Vandenberghe, Raf Sciot, Bart Dermaut, D. Goossens, Julie van der Zee, Tim De Pooter, Jurgen Del‐Favero, Patrick Santens, Peter De Jonghe, Peter P. De Deyn, Christine Van Broeckhoven, Marc Cruts	3
17	Heterogeneity in motoneuron disease 2007 ·Trends in Neurosciences ·Diether Lambrechts, Wim Robberecht, Peter Carmeliet	14
18	Excitotoxicity and Amyotrophic Lateral Sclerosis 2005 ·Neurodegenerative Diseases ·(unknown), Maarten Dewil, Wim Robberecht, Ludo Van Den Bosch	137
19	Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis 2005 ·Neuroreport ·Maarten Dewil, (unknown), Sofie Starckx, Ghislain Opdenakker, Ludo Van Den Bosch, Wim Robberecht	29
20	Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons 2000 ·Journal of the Neurological Sciences ·Ludo Van Den Bosch, Wim Vandenberghe, Hugo Klaassen, (unknown), Wim Robberecht	191

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact